Waldencast (WALD) Expected to Announce Quarterly Earnings on Tuesday

Waldencast (NASDAQ:WALD) will likely be announcing its earnings results after the market closes on Tuesday, March 18th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $70.43 million for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Waldencast Price Performance

Shares of NASDAQ:WALD opened at $3.12 on Tuesday. The firm’s 50 day simple moving average is $3.29 and its 200-day simple moving average is $3.47. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.21. Waldencast has a one year low of $2.41 and a one year high of $7.54.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on WALD shares. Canaccord Genuity Group boosted their target price on shares of Waldencast from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Friday, November 22nd. DA Davidson boosted their target price on shares of Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a report on Wednesday, December 4th. TD Cowen initiated coverage on shares of Waldencast in a research note on Monday, December 16th. They set a “hold” rating and a $4.30 target price on the stock. Finally, Telsey Advisory Group reaffirmed an “outperform” rating and issued a $6.00 target price on shares of Waldencast in a research report on Monday, November 18th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $5.76.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.